Shoulder impingement and rotator-cuff pathology describe a shoulder-specific group of problems that has been studied with pulsed electromagnetic fields (PEMF) in a small number of randomized trials. This page reports what those trials and one systematic review found; it does not make a claim about what any PEMF device will do for an individual.
What researchers have studied
The research on this page concerns shoulder impingement syndrome, subacromial impingement syndrome, or rotator-cuff tendinopathy. These labels overlap clinically but are not identical. Some trials added PEMF to exercise, cold packs, activity modification, an anti-inflammatory medicine, or focused extracorporeal shock wave therapy. Their results therefore describe combined study programs, not PEMF in isolation in every setting.
For a broader discussion of tendon conditions across body sites, see PEMF and tendonitis. That page covers general tendon conditions; this page is limited to shoulder-specific impingement and rotator-cuff trials. It does not use Achilles, elbow, animal, cell-culture, low-back, or osteoarthritis research as stand-ins for a shoulder result.
The most recent review located four randomized controlled trials with 252 participants. Three paired PEMF or sham PEMF with exercise-based care; one paired electromagnetic transduction therapy, a high-energy PEMF format, or sham treatment with focused shock wave therapy. The studies used clinic-style equipment and did not test a standardized consumer device format.
The studies
Wang et al. 2025 systematic review and meta-analysis
Wang and colleagues searched PubMed, the Cochrane Library, and Embase through June 19, 2024, then pooled four randomized trials involving 252 people with shoulder impingement syndrome or rotator-cuff tendinopathy. Three trials and 166 participants contributed short-term pain and function data. Short-term pain was SMD -0.34 (95% CI -0.66 to -0.01), an interval close to zero. Short-term function was SMD 0.40 (95% CI 0.08 to 0.73; n=166), and long-term function was SMD 0.60 (95% CI 0.33 to 0.88; three trials; n=212).
The same review found no statistically significant long-term pain difference: SMD -0.47 (95% CI -0.98 to 0.04; three trials). It rated the included trials 8 to 9 on the PEDro scale, but noted differences in field parameters, session schedules, and co-interventions. One long-term comparison included shock wave therapy in both groups rather than exercise. The review was published in 2025, not 2024; 2024 is the end date of its search.
Wang H-Y, Chen Y-J, Huang I-C, Lin C-R, Lin K-L, Chen C-H. “The Effectiveness of Pulsed Electromagnetic Field Therapy in Patients With Shoulder Impingement Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.” PLOS One. 2025;20(5):e0323837. PMID: 40388433. DOI: 10.1371/journal.pone.0323837.
Aktas, Akgun, and Cakmak 2007
This double-blind randomized controlled trial enrolled 46 people with unilateral subacromial impingement syndrome. For three weeks, both groups received pendulum exercises, cold packs, activity restriction, and meloxicam. One group also received PEMF and the other sham PEMF, for 25 minutes, five days weekly. Pain, Constant score, and a shoulder disability questionnaire were measured.
Both groups had better scores after the program than at baseline, with no statistically significant active-versus-sham difference for any outcome. Because the broader rehabilitation program was shared, the study does not isolate a field-session result. Follow-up ended after three weeks.
Aktas I, Akgun K, Cakmak B. “Therapeutic Effect of Pulsed Electromagnetic Field in Conservative Treatment of Subacromial Impingement Syndrome.” Clinical Rheumatology. 2007;26(8):1234-1239. PMID: 17086382. DOI: 10.1007/s10067-006-0464-2.
Galace de Freitas et al. 2014
Galace de Freitas and colleagues conducted a double-blind, randomized, placebo-controlled trial in 56 people with shoulder impingement syndrome. Participants received three weeks of active or placebo PEMF, followed by the same shoulder-strengthening exercise program. Assessments occurred at baseline, three weeks, nine weeks, and three months. Ten participants did not complete the study.
Pain and function changed from baseline within the active group, but the abstract reports no statistically significant between-group difference for any outcome and advises careful interpretation. The placebo phase and shared later exercise are strengths. The study does not compare a retail device with the outpatient-rehabilitation equipment.
Galace de Freitas D, Marcondes FB, Monteiro RL, Rosa SG, Maria de Moraes Barros Fucs P, Fukuda TY. “Pulsed Electromagnetic Field and Exercises in Patients With Shoulder Impingement Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.” Archives of Physical Medicine and Rehabilitation. 2014;95(2):345-352. PMID: 24139986. DOI: 10.1016/j.apmr.2013.09.022.
Klüter et al. 2018
Klüter and colleagues randomized 86 people with rotator-cuff tendinopathy to three focused shock wave therapy sessions plus either eight sessions of electromagnetic transduction therapy, described as a high-energy PEMF format, or sham treatment. At 24 weeks, the combined active-format group had greater visual-analog-scale pain reduction and Constant-Murley score increase than the shock-wave-plus-sham group.
This had the longest follow-up of the four review trials. It is a combined-intervention study, so the result applies to the package tested, not PEMF alone, another field system, or a home mat. The review noted that therapists were not blinded, unlike in the other trials.
Klüter T, Krath A, Stukenberg M, Gollwitzer H, Harrasser N, Knobloch K, Maffulli N, Hausdorf J, Gerdesmeyer L. “Electromagnetic Transduction Therapy and Shockwave Therapy in 86 Patients With Rotator Cuff Tendinopathy: A Prospective Randomized Controlled Trial.” Electromagnetic Biology and Medicine. 2018;37(4):175-183. PMID: 30183430. DOI: 10.1080/15368378.2018.1499030.
Kandemir et al. 2024
Kandemir and colleagues randomized 80 people with subacromial impingement syndrome in a rehabilitation clinic. The intervention group received PEMF plus exercise; the comparison group received sham PEMF plus the same exercise program. Both schedules involved 20 sessions, five days each week. Outcomes included pain, Constant-Murley score, disability, quality of life, range of motion, and strength at the end of treatment and at 12 weeks.
Both groups improved in most measures from baseline. The article reports larger improvements in most parameters in the active-format group at both follow-ups. The sham comparison and shared exercise program strengthen the comparison, but the findings apply to this clinic protocol with exercise, not another diagnosis, schedule, field specification, or device format.
Kandemir O, Adar S, Dündar Ü, Tokta? H, Ye?il H, Ero?lu S, Eyvaz N. “Effectiveness of Pulse Electromagnetic Field Therapy in Patients With Subacromial Impingement Syndrome: A Double-Blind Randomized Sham Controlled Study.” Archives of Physical Medicine and Rehabilitation. 2024;105(2):199-207. PMID: 37820844. DOI: 10.1016/j.apmr.2023.09.020.
Osti, Del Buono, and Maffulli 2015
This randomized controlled study examined a different shoulder setting: 66 people after arthroscopic repair of small to medium rotator-cuff tears. All participants followed the same postoperative rehabilitation program and were assigned to PEMF or placebo treatment. At three months, the PEMF group had statistically significant between-group differences in pain, range of motion, and UCLA and Constant scores.
At the last follow-up, at least two years after surgery, the investigators found no significant between-group differences in clinical or functional outcomes. This is a useful long-term null finding, but the population had surgery for a tear rather than nonoperative shoulder impingement or tendinopathy. It should not be blended with the impingement trials as though the diagnoses and treatment context were the same.
Osti L, Del Buono A, Maffulli N. “Pulsed Electromagnetic Fields After Rotator Cuff Repair: A Randomized, Controlled Study.” Orthopedics. 2015;38(3):e223-e228. PMID: 25760511. DOI: 10.3928/01477447-20150305-61.
How strong is this evidence?
The evidence is small, mixed, and specific to the study settings. The review’s four trials totalled 252 participants, with individual trial samples of 40 to 86. It estimated a short-term pain difference of SMD -0.34 (95% CI -0.66 to -0.01). The interval barely excludes no difference, so it does not support a broad conclusion from the point estimate alone. The review also found no statistically significant long-term pain difference, SMD -0.47 (95% CI -0.98 to 0.04). Its function estimates were SMD 0.40 (95% CI 0.08 to 0.73) shortly after treatment and SMD 0.60 (95% CI 0.33 to 0.88) at longer follow-up. Those are pooled results, not a result for every shoulder diagnosis or device.
The trials did have design strengths. All were randomized, most used sham treatment, and the review assigned PEDro scores of 8 or 9. At the same time, protocols varied from 3 Hz to 50 Hz, 3 mT to 80 mT, 20 to 30 minutes per session, and three to four weeks. Three trials shared exercise-based care across groups, while the tendinopathy trial shared focused shock wave therapy. Co-interventions complicate any attempt to assign every observed change to the field component.
Follow-up also varied. The review’s maximum follow-up was 24 weeks, while the postoperative rotator-cuff study found early differences but no between-group difference at a minimum of two years. The 2007 trial and the 2014 trial reported no statistically significant between-group outcome difference. Diagnosis matters as well: impingement syndrome, subacromial impingement, rotator-cuff tendinopathy, and surgically repaired tears are not interchangeable. Reporting was inconsistent for adverse events, and the review said that this prevented a definitive safety assessment for this shoulder population.
What this means if you are considering a PEMF device
A format-focused reading begins with the actual trial setup. The exercise-based studies used session-based PEMF or sham PEMF in outpatient rehabilitation or a physical medicine setting. The review tabulated 25- to 30-minute sessions in those studies and 20-minute sessions twice weekly in the electromagnetic-transduction-plus-shock-wave study. Three trials used exercise-based care in both groups; one used focused shock wave therapy.
Those study arrangements are not the same as an unattended home mat, a portable applicator, or a retail unit. The papers do not establish equivalence among those formats, their output specifications, or their schedules. A product description can be read as product information, while a trial can be read as evidence about the named population, equipment, comparison, and follow-up. Neither should be substituted for the other.
For a practical comparison, look for written information on the applicator or mat, controls, power source, included components, manual, warranty, and return terms. Compare those details with what the trial reports, including any exercise or clinic-based co-intervention.
Questions to ask before buying
- Does the seller provide the applicator dimensions, output specifications, controls, and included components in writing?
- Is the cited study actually about shoulder impingement, rotator-cuff tendinopathy, or postoperative repair, and which of those is it?
- Did the cited trial compare active treatment with a sham treatment, and what care did both groups receive?
- Does the product documentation state the warranty length, return window, repair process, and any restocking fees?
- Can the seller provide the complete manual and contraindication information before purchase?
This page summarizes published research for reference. It is not medical advice, and nothing here is a claim that any PEMF device treats, cures, or prevents any condition. PEMF is not appropriate for everyone — review PEMF contraindications and talk with your own physician before beginning any new therapy, particularly if you have an implanted electronic device, are pregnant, or are being treated for a serious medical condition.